IPF cohort | Subjects n | Age yrs | FVC % pred | DL,CO % pred | CPI |
Anti-reflux medication used | 35 | 68 | 69.0±18.5 | 44.4±17.3 | 53.7±14.4 |
Anti-reflux medication not used | 39 | 65 | 69.2±16.9 | 50.6±19.5 | 48.2±13.9 |
Reflux symptoms present# | 16 | 64 | 74.2±20.8 | 50.5±23.4 | 46.9±16.9 |
Reflux symptoms absent | 58 | 67 | 67.7±16.5 | 46.9±17.2 | 51.9±13.5 |
Anti-reflux medication used | 25 | 67 | 66.0±13.0 | 49.9±17.4 | 53.4±12.4 |
Anti-reflux medication not used | 33 | 69 | 69.0±18.8 | 44.7±17.1 | 53.7±14.2 |
Data are presented as mean±sd, unless otherwise stated. None of the data were statistically significant. FVC: forced vital capacity; % pred: % predicted; DL,CO: diffusing capacity of the lung for carbon monoxide; CPI: composite physiologic index. #: 15 out of the 16 subjects were taking anti-reflux medication.